Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Genes & development - 1 Aug 2003

Fox Casey J, Hammerman Peter S, Cinalli Ryan M, Master Stephen R, Chodosh Lewis A, Thompson Craig B

Abstract excerpt

Growth factor withdrawal results in the termination of factor-dependent transcription. One transcript that declines rapidly following growth factor deprivation of hematopoietic cells is the serine/threonine kinase pim-2. When constitutively expressed, Pim-2 conferred long-term resistance to a variety of apoptotic stimuli including growth factor withdrawal and endogenous levels of Pim-2 contributed to growth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Interleukin-3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lactates

Share to Membrane Potentials

Share to Sirolimus

Share to Staurosporine

Share to Thapsigargin

Share to Transgenes

Source

Open in PubMed Open full text

Identifiers

PMID: 12869584
DOI: 10.1101/gad.1105003
PMCID: PMC196230

Genes

BAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.PMID 12869584Read ↗

Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survivalSemantic proximity Read ↗

The PIM kinases in hematological cancersSemantic proximity Read ↗

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeuticsSemantic proximity Read ↗

Targeting PIM Kinases to Overcome Therapeutic Resistance in CancerSemantic proximity Read ↗

A review on PIM kinases in tumorsSemantic proximity Read ↗

Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.Semantic proximity Read ↗

Why Target PIM1 for Cancer Diagnosis and Treatment?Semantic proximity Read ↗

Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.Semantic proximity Read ↗

Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival.Semantic proximity Read ↗

Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell LymphomaSemantic proximity Read ↗

PIM2 inhibition promotes MCL1 dependency in plasma cells involving integrated stress response-driven NOXA expressionSemantic proximity Read ↗

Roles of Pim‐3, a novel survival kinase, in tumorigenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.